Price Alert

Chemomab Therapeutics Ltd... (CMMB)

NASDAQ: CMMB · Real-Time Price · USD

0.94

0.04 (4.76%)

At close: Aug 15, 2025, 3:58 PM

0.95

1.58%

After-hours: Aug 15, 2025, 07:26 PM EDT

Chemomab Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	6.07M	6.6M	5.04M	4.74M	9.37M	9.23M	10.38M	20.77M	13.52M	10.74M	9.88M	13.83M	14.69M	37.74M	45.4M	58.18M
Short-Term Investments	8.2M	12.78M	7.69M	11.21M	10.49M	12.22M	16.21M	11.94M	26.37M	35.73M	41.84M	43.58M	46.48M	26.52M	21.52M	23K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	77K	77K	85K	55K	53K	53K	4K
Other Long-Term Assets	378.38K	428K	472K	516K	559K	602.99K	646K	690K	733K	776K	821K	864K	908K	952K	995K	51K
Receivables	263K	439K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.26M	3.11M	1.93M	179K	1.57M	1.92M	n/a
Inventory	n/a	n/a	n/a	-885K	-1.04M	-993	72.88K	-12.94M	n/a	-37.98M	-44.95M	-45.51M	-1.35M	-28.1M	-23.44M	n/a
Other Current Assets	76K	75K	654K	885.01K	365K	n/a	1.12K	1.07M	536K	n/a	n/a	n/a	n/a	n/a	n/a	1.32M
Total Current Assets	16.04M	19.89M	13.46M	16.84M	20.9M	22.37M	27.7M	33.78M	41.74M	48.73M	54.83M	59.34M	62.69M	65.84M	68.83M	59.52M
Property-Plant & Equipment	539K	577K	617K	656K	695K	448.99K	498K	545K	594K	641K	650K	667K	702K	593K	635K	545K
Goodwill & Intangibles	6.62K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	924K	1M	1.09M	1.17M	1.25M	1.05M	1.14M	1.24M	1.33M	1.49M	1.55M	1.62M	1.67M	1.6M	1.68M	600K
Total Assets	16.96M	20.9M	14.54M	18.01M	22.15M	23.42M	28.85M	35.01M	43.06M	50.22M	56.38M	60.96M	64.35M	67.44M	70.52M	60.12M
Account Payables	666K	386K	1.11M	527K	516K	730.99K	2.35M	2.22M	1.69M	1.25M	1.43M	1.49M	1.34M	481K	472K	2.08M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	-2.55M	n/a	n/a	n/a	n/a	115K	n/a	n/a	132K	n/a	n/a	61K	72K	69K
Other Current Liabilities	874K	727K	9.00	n/a	3.42M	3.01M	n/a	3.05M	n/a	n/a	1.58M	n/a	n/a	576K	905K	1.89M
Total Current Liabilities	3.22M	4.35M	4.31M	4.4M	4.84M	5.37M	6.83M	7M	6.75M	5.48M	4.39M	3.52M	2.65M	1.63M	2.16M	4.63M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	0.08	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	209K	230K	251K	280K	316K	5K	33K	62K	91K	118K	148K	203K	237K	298K	320K	328K
Total Liabilities	3.43M	4.58M	4.56M	4.68M	5.15M	5.37M	6.86M	7.06M	6.84M	5.59M	4.54M	3.72M	2.89M	1.93M	2.48M	4.96M
Total Debt	324K	342K	360K	390K	392K	110K	141K	177K	214K	244K	280K	319K	343K	359K	392K	397K
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-102.62M	-99.66M	-96.18M	-92.55M	-88.68M	-84.62M	-80.54M	-72.57M	-63.82M	-55.55M	-47.47M	-41.28M	-36.17M	-31.14M	-28.17M	-25.4M
Comprehensive Income	0.00	n/a	n/a	0.00	n/a	-0.00	-0.00	0.00	-0.00	-0.00	n/a	-0.00	0.00	n/a	0.00	n/a
Shareholders Equity	13.54M	16.32M	9.99M	13.33M	17M	18.04M	21.99M	27.95M	36.22M	44.62M	51.84M	57.24M	61.47M	65.51M	68.04M	55.16M
Total Investments	8.2M	12.78M	7.69M	11.21M	10.49M	12.22M	16.21M	11.94M	26.37M	35.73M	41.84M	43.58M	46.48M	26.52M	21.52M	27K